Pregnancy loss and antiphospholipid antibodies

Lupus

Volumn 7, Issue SUPPL. 2, 1998, Pages

  Lockshin, M D ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Antiphospholipid antibody; Fetal outcome; Lupus; Placenta; Pregnancy loss

Indexed keywords

HEPARIN; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CONFERENCE PAPER; FEMALE; HUMAN; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREMATURITY; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION; SURVIVAL; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0031730510     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339800700219     Document Type: Conference Paper

References (51)

1. Lakasing L, Poston L. Adverse pregnancy outcome in the anti-phospholipid syndrome: focus for future research Lupus 1997; 6: 681-684.
2. Lima F et al. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131-136
3. Rai R, Cohen H, Dave M, Regan L Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-257.
4. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss' treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.
5. Lynch A et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study Ann Intern Med 1994; 120: 470-475
6. Kutteh WH. Antiphospholipid antibodies and reproduction. J Reprod Immunol 1997, 35: 151-171.
7. Yetman DL, Kutteh WH Antiphospholipid antibody panels and recurrent pregnancy loss prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996, 66: 540-546.
8. Branch DW et al. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience Obstet Gynecol 1992; 80: 614-620.
9. Stephanson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996; 66. 24-29.
10. MacLean MA et al. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynecol 1994, 101: 103-106
11. Laskin CA et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337: 148-153.
12. Katano K et al Postpartum thrombosis after a successful pregnancy in a recurrent aborter positive for antiphospholipid antibodies. Gynecol Obstet Invest 1998; 45: 81-84.
13. Geva E et al Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization Fertil Steril 1994; 62: 802-806.
14. Birkenfeld A et al. Incidence of autoimmune antibodies in failed embryo transfer cycles. Am J Reprod Immunol 1994; 31: 65-68.
15. Kaider BD, Price DE, Roussev RG, Coulam CB Antiphospholipid antibody prevalence in patients with IVF failure. Am J Reprod Immunol 1996; 35: 388-393.
16. Birdsall MA et al. Antiphospholipid antibodies in women having in-vitro fertilization. Hum Reprod 1996; 11: 1185-1189.
17. Ramsey-Goldman R et al. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am J Epidemiol 1993; 138. 1057-1069.
18. Aoki K et al. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome; correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol 1995; 172: 926-931.
19. Salafia CM, Cowchoek FS. Placental pathology of antiphospholipid antibodies - a descriptive study. Am J Perinatol 1997; 14 435-441
20. Magid MS et al Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol, 1998, in press
21. Katano K. et al. Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera. Lupus 1995, 4. 304-308.
22. Peaceman AM, Rehnberg KA. The effect of aspirin and indomethacin on prostacyeline and thromboxane production by placental tissue incubated with immunoglobulin G fractions from patients with lupus anticoagulant. Am J Obstet Gynecol 1995; 173: 1391-1396
23. Di Simone N et al. Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by anti-phospholipid antibody-containing sera. Hum Reprod 1997; 12: 2061-2065
24. Sammaritano LR et al. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein J Clin Immunol 1992; 12. 27-35
25. Rand JH et al. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am J Obstet Gynecol 1997; 177: 918-923
26. Rand JH et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997; 337: 154-160
27. LaRosa L et al. Beta-2-glycoprotein I and placental anticoagulant protein 1 in placentae from patients with antiphospholipid antibody syndrome J Rheumatol 1994, 21: 1684-1693.
28. Ziporen L, Blank M, Shoenfeld Y. Animal models for antiphospholipid syndrome in pregnancy. Rheum Dis Clin North Am 1997; 23: 99-117
29. Gharavi AE, Sammantano LR, Bovastro SL, Wilson WL. Specificities and characteristics of beta-2-glycoprotein I-induced antiphospholipid antibodies. J Lab Clin Med 1995; 125: 775-778.
30. Sthoeger ZM et al Anticardiolipin, but not the 16/6 Id anti-DNA antibody induces pregnancy failure Immunol Lett 1996; 49: 117-122.
31. Piona A et al. Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice. Scand J Immunol 1995, 41: 427-432.
32. Ikematsu W et al Human anticardiolipin mAbs cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum 1998; 41: 1026-1039.
33. Branch DW, Silver RM Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss. Lupus 1996: 5. 409-413.
34. Vogt E, Ng Ak, Rote NS A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996; 174: 700-707
35. Sanson BJ et al. The risk of abortion and stillbirth in antithrombin-protein C-, and protein S-deficient women. Thromb Haemost 1996; 75: 387-388
36. Shoenfeld Y, Fishman P. Role of IL-3 in the antiphospholipid syndrome. Lupus 1994; 3 259-261.
37. Sammantano LR et al. Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis Arthritis Rheum 1997, 40. 1998-2006
38. Nelson JL et al. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329: 466-471.
39. Brennan P, Payton T, Ollier B, Silman A Maternal exposure to paternal HLA does not explain the postpartum increase in rheumatoid arthritis. Gen Epidemiol 1996, 13: 411-418
40. Bianchi DW et al Male fetal progenitor cells persist in maternal blood for an long as 27 years postpartum Proc Natl Acad Sci USA 1996: 93: 705-708.
41. Nelson JL et al Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351: 559-562
42. Artlett CM, Smith JB, Jimenez SA Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis N Engl J Med 1998; 338: 1186-1191.
43. Mullinax GL, Mullinax F Chimerism in lupus erythematosus Identification of offspring-derived cells in patients with systemic lupus erythematosus. Lupus 1998; 7: s14
44. Kutten WH, Ermel I.D. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol 1996; 35. 402-407.
45. Ermel LD, Marshburn PB, Kutteh WH Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL) Am J Reprod Immunol 1995: 33: 14-20
46. Blank M et al Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome Arthritis Rheum 1998; 41: 224-232.
47. Kanai Y et al Therapeutic plasmapheresis for the treatment of pregnant systemic lupus erythematosus patients with antiphospholipid antibodies. Lupus 1998, 7: s114
48. Harger JH et al Low-dose aspirin and prednisone treatment of pregnancy loss caused by lupus anticoagulants J Perinatol 1995; 15: 463-469.
49. Barbour LA et al. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994; 170: 862-869.
50. Ross G, Sammaritano LR, Nass R, Lockshin MD. Learning disabilities in offspring of women with systemic lupus erythematosus. Arthritis Rheum 1993, 36: s87.
51. McAllister DL et al The influence of systemic lupus erythematosus on fetal development: cognitive, behavioral, and health trends. J Int Neuropsychol Soc 1997; 3: 370-6.